Immediate Impact
61 standout
Citing Papers
Cancer therapy with antibodies
2024 Standout
New frontiers in immune checkpoint B7-H3 (CD276) research and drug development
2023 Standout
Works of Justin Smith being referenced
A phase I/II trial of iodine-131–tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas
2000
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Justin Smith | 81 | 29 | 36 | 179 | 116 | 23 | 329 | |
| Elizabeth Wiley | 44 | 42 | 6 | 100 | 22 | 19 | 307 | |
| Nagavalli Somasundaram | 22 | 50 | 18 | 93 | 18 | 37 | 338 | |
| Elizabeth C. Chase | 31 | 29 | 17 | 141 | 13 | 14 | 283 | |
| Miguel Morey | 75 | 14 | 21 | 93 | 11 | 21 | 362 | |
| Fabio Girardi | 20 | 15 | 8 | 32 | 47 | 26 | 358 | |
| Surai Jones | 21 | 23 | 49 | 87 | 33 | 12 | 276 | |
| Jennifer A. Wong | 26 | 31 | 34 | 31 | 20 | 17 | 342 | |
| Giacomo Loseto | 6 | 9 | 52 | 85 | 26 | 24 | 330 | |
| Geoffrey Dean | 33 | 43 | 23 | 101 | 14 | 32 | 336 | |
| Paul C. Lee | 29 | 18 | 19 | 41 | 26 | 30 | 321 |
All Works
Login with ORCID to disown or claim papers
Loading papers...